Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C. (Q30402571)

12 August 2017

Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C. (English)

1 reference

12 August 2017

Keisuke Osakabe

1

1 reference

12 August 2017

Naohiro Ichino

2

1 reference

12 August 2017

Toru Nishikawa

3

1 reference

12 August 2017

Hiroko Sugiyama

4

1 reference

12 August 2017

Miho Kato

5

1 reference

12 August 2017

Ai Shibata

6

1 reference

12 August 2017

Wakana Asada

7

1 reference

12 August 2017

Naoto Kawabe

8

1 reference

12 August 2017

Senju Hashimoto

9

1 reference

12 August 2017

Michihito Murao

10

1 reference

12 August 2017

Takuji Nakano

11

1 reference

12 August 2017

Hiroaki Shimazaki

12

1 reference

12 August 2017

Toshiki Kan

13

1 reference

12 August 2017

Kazunori Nakaoka

14

1 reference

12 August 2017

Yuka Takagawa

15

1 reference

12 August 2017

Masashi Ohki

16

1 reference

12 August 2017

Takamitsu Kurashita

17

1 reference

12 August 2017

Tomoki Takamura

18

1 reference

12 August 2017

Kentaro Yoshioka

19

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2015

1 reference

World Journal of Gastroenterology

12 August 2017

1 reference

12 August 2017

21

1 reference

12 August 2017

35

1 reference

12 August 2017

10215-10223

1 reference

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Antiviral activity and resistance of HCV NS5A replication complex inhibitors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Acoustic radiation force impulse imaging for evaluation of antiviral treatment response in chronic hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Current progress in the treatment of chronic hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Preliminary study of two antiviral agents for hepatitis C genotype 1.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Telaprevir for previously untreated chronic hepatitis C virus infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Boceprevir for untreated chronic HCV genotype 1 infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Diagnosis, management, and treatment of hepatitis C: an update

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Changes of non-invasive markers and FibroScan values during HCV treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

American Gastroenterological Association technical review on the management of hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Diagnosis, management, and treatment of hepatitis C

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Hepatitis C: the clinical spectrum of the disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

20 June 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Efficacy of non-invasive elastometry on staging of hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Liver stiffness diminishes with antiviral response in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Significance of liver stiffness measurement by acoustic radiation force impulse (ARFI) among hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Factors which influence the accuracy of acoustic radiation force impulse (ARFI) elastography for the diagnosis of liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I35.10215

Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572803

Reduction of liver stiffness by antiviral therapy in chronic hepatitis B

26 November 2018

1 reference

12 December 2020

Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study

1 reference

12 December 2020

Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results

1 reference

12 December 2020

1 reference

12 December 2020

Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

1 reference

12 December 2020

1 reference

12 December 2020

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

1 reference

12 December 2020

FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

1 reference

12 December 2020

10.3748/WJG.V21.I35.10215

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

1 reference